郭继鸿.β受体阻滞剂在心律失常治疗中的应用[J].中国心脏起搏与心电生理杂志,2007(01).

施仲伟.阿替洛尔的心脏保护作用缺乏证据[J].中华医学杂志,2005(13).

国家药典委员会编,诸骏仁,桑国卫主编.中华人民共和国药典临床用药须知[M].人民卫生出版社,2005.

Silvia G. Priori,Arthur A. Wilde,Minoru Horie,Yongkeun Cho,Elijah R. Behr,Charles Berul,Nico Blom,Josep Brugada,Chern-En Chiang,Heikki Huikuri,Prince Kannankeril,Andrew Krahn,Antoine Leenhardt,Arthur Moss,Peter J. Schwartz,Wataru Shimizu,Gordon Tomaselli,Cynthia Tracy.HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes[J].Heart Rhythm,2013(8).

Tengxian Liu,Martin Traebert,Haisong Ju,Willi Suter,Donglin Guo,Peter Hoffmann,Peter R. Kowey,Gan-Xin Yan.Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: A blinded validation[J].Heart Rhythm,2012(10).

Not All Beta-Blockers Are Equal in the Management of Long QT Syndrome Types 1 and 2[J].Journal of the American College of Cardiology,2012(20).

Alessandra Besana,Dao W. Wang,Alfred L. George,Peter J. Schwartz.Nadolol Block of Nav1.5 Does Not Explain Its Efficacy in the Long QT Syndrome[J].Journal of Cardiovascular Pharmacology,2012(3).

ILANGOLDENBERG,JAMESBRADLEY,ARTHURMOSS,SCOTTMCNITT,SLAVAPOLONSKY,JENNIFER L.ROBINSON,MARKANDREWS,WOJCIECHZAREBA.Beta‐Blocker Efficacy in High‐Risk Patients with the Congenital Long‐QT Syndrome Types 1 and 2: Implications for Patient Management[J].Journal of Cardiovascular Electrophysiology,2010(8).

Christian Jons,Arthur J. Moss,Ilan Goldenberg,Judy Liu,Scott McNitt,Wojciech Zareba,Ming Qi,Jennifer L. Robinson.Risk of Fatal Arrhythmic Events in Long QT Syndrome Patients After Syncope[J].Journal of the American College of Cardiology,2010(8).

Janet McGill.Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence[J].Vascular Health and Risk Management,2010.

ANTONIO E.LACERDA,YURI A.KURYSHEV,GAN‐XINYAN,ALBERT L.WALDO,ARTHUR M.BROWN.Vanoxerine: Cellular Mechanism of a New Antiarrhythmic[J].Journal of Cardiovascular Electrophysiology,2010(3).

Peter J. Schwartz,Marco Stramba-Badiale,Lia Crotti,Matteo Pedrazzini,Alessandra Besana,Giuliano Bosi,Fulvio Gabbarini,Karine Goulene,Roberto Insolia,Savina Mannarino,Fabio Mosca,Luigi Nespoli,Alessandro Rimini,Enrico Rosati,Patrizia Salice,Carla Spazzolini.Prevalence of the Congenital Long-QT Syndrome[J].Circulation,2009(18).

John R. Bankston,Robert S. Kass.Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3[J].Journal of Molecular and Cellular Cardiology,2009(1).

G Michael Vincent,Peter J. Schwartz,Isabelle Denjoy,Heikki Swan,Candice Bithell,Carla Spazzolini,Lia Crotti,Kirsi Piippo,Jean-Marc Lupoglazoff,Elizabeth Villain,Silvia G. Priori,Carlo Napolitano,Li Zhang.High Efficacy of β-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment “Failures”[J].Circulation,2009(2).

R. Chatrath,C. M. Bell,M. J. Ackerman.β-Blocker Therapy Failures in Symptomatic Probands with Genotyped Long-QT Syndrome[J].Pediatric Cardiology,2004(5).

Arthur J. Moss,Wojciech Zareba,W. Jackson Hall,Peter J. Schwartz,Richard S. Crampton,Jesaia Benhorin,G. Michael Vincent,Emanuela H. Locati,Silvia G. Priori,Carlo Napolitano,Aharon Medina,Li Zhang,Jennifer L. Robinson,Katherine Timothy,Jeffrey A. Towbin,Mark L. Andrews.Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome[J].Circulation: Journal of the American Heart Association,2000.

Michael R. Bristow.β-Adrenergic Receptor Blockade in Chronic Heart Failure[J].Circulation: Journal of the American Heart Association,2000(5).

A Tolerance Study of Single and Multiple Dosing of the Selective Dopamine Uptake Inhibitor GBR 12909 in Healthy Subjects[J].International Clinical Psychopharmacology,1990(4).